Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 60 views

    Clinical Research: - Sai Krishna

    Uploaded by

    Bob Bin
    This document summarizes the key stages of clinical drug research and development. It discusses the stages of discovery, preclinical testing, clinical trials, patient protections, and reasons for low participation rates. Clinical research determines a drug's safety and effectiveness through a series of phases, including preclinical animal studies, clinical trials with human subjects in 4 phases, and regulatory approval. Patients are protected by informed consent, institutional review boards, and data safety monitoring boards. However, many patients do not participate in clinical trials due to lack of awareness, access, or concerns about risks.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd

    Clinical Research: - Sai Krishna

    Uploaded by

    Bob Bin
    60 views27 pages
    This document summarizes the key stages of clinical drug research and development. It discusses the stages of discovery, preclinical testing, clinical trials, patient protections, and reasons for low participation rates. Clinical research determines a drug's safety and effectiveness through a series of phases, including preclinical animal studies, clinical trials with human subjects in 4 phases, and regulatory approval. Patients are protected by informed consent, institutional review boards, and data safety monitoring boards. However, many patients do not participate in clinical trials due to lack of awareness, access, or concerns about risks.

    Original Title

    Clinical Research

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PPT, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document summarizes the key stages of clinical drug research and development. It discusses the stages of discovery, preclinical testing, clinical trials, patient protections, and reasons for low participation rates. Clinical research determines a drug's safety and effectiveness through a series of phases, including preclinical animal studies, clinical trials with human subjects in 4 phases, and regulatory approval. Patients are protected by informed consent, institutional review boards, and data safety monitoring boards. However, many patients do not participate in clinical trials due to lack of awareness, access, or concerns about risks.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Download as ppt, pdf, or txt
    60 views27 pages

    Clinical Research: - Sai Krishna

    Uploaded by

    Bob Bin
    This document summarizes the key stages of clinical drug research and development. It discusses the stages of discovery, preclinical testing, clinical trials, patient protections, and reasons for low participation rates. Clinical research determines a drug's safety and effectiveness through a series of phases, including preclinical animal studies, clinical trials with human subjects in 4 phases, and regulatory approval. Patients are protected by informed consent, institutional review boards, and data safety monitoring boards. However, many patients do not participate in clinical trials due to lack of awareness, access, or concerns about risks.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Download as ppt, pdf, or txt
    of 27

    CLINICAL RESEARCH

    -SAI KRISHNA

    STAGES OF DRUG DEVELOPEMENT


    Discovery Product Characterization Formulation, Delivery, Packaging Development Pharmacokinetics And Drug Disposition Pharmacokinetic

    Preclinical Toxicology Testing - Acute Studies - Repeated Dose Studies - Genetic Toxicity Studies - Reproductive Toxicity Studies - Carcinogenicity Studies - Toxicokinetic Studies

    Bioanalytical Testing Clinical Trials

    Clinical research is a branch of medical science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease.

    The term clinical research refers to the entire biography of a drug from its inception in the lab to its introduction to the consumer market and beyond. Once the promising candidate or the molecule is identified in the lab, it is subjected to preclinical studies or animal studies where different aspects of the drug (including its efficacy and toxicity) are studied.

    In the United States, the data obtained from the pre-clinical studies are submitted as an Investigational New Drug (IND) to the Food and Drug Administration (FDA) for permission to conduct human studies.

    In the European Union, the European Medicines Agency (EMEA) acts in a similar fashion for studies conducted in their region. These human studies are conducted in four phases in research subjects that give consent to participate in the clinical trials

    The Code of Federal Regulations (CFR) defines a clinical trial as the clinical investigation of a drug that is administered or dispensed to, or used involving one or more human subjects

    Three Important Key Words


    Experimental unit Treatment Evaluation of the treatment

    Experimental unit
    Referred as a subject from a target population under study Usually used to specify the intended study population to which the results of the study are inferenced

    Treatment
    A treatment can be a Placebo Combination of a new pharmaceutical identity New diet Surgical procedure Diagnostic test Medical device Health education proogram No treatment

    Evaluation
    Effectiveness and safety of treatment Pharmacoeconomics

    CLINICAL TRIALS
    Clinical trials are generally considered to be biomedical or health-related research studies in human beings that follow a predefined protocol. 2 TYPES I) Interventional II) Observational types

    I)Interventional studies are those in which the research subjects are assigned by the investigator to a treatment or other intervention, and their outcomes are measured. II)Observational studies are those in which individuals are observed and their outcomes are measured by the investigators.

    STEPS INVOLVED IN CLINICAL RESEARCH EFFORT

    BENEFITS OF PARTICIPATION
    Possible benefits: Patients will receive, at a minimum, the best standard treatment (if one exists) If the new treatment or intervention is proven to work, patients may be among the first to benefit Patients have a chance to help others and improve patient care

    RISK OF PARTICIPATION
    Possible risks: New treatments or interventions under study are not always better than, or even as good as, standard care Even if a new treatment has benefits, it may not work for every patient Health insurance and managed care providers do not always cover clinical trials

    PATIENT PROTECTION
    There have, unfortunately, been past abuses in patient protection Federal regulations ensure that people are told about the benefits, risks, and purpose of research before they agree to participate

    HOW ARE PATIENTS RIGHTS PROTECTED Informed consent Scientific review Institutional review boards (IRBs) Data safety and monitoring boards (DSMBs)

    INFORMED CONSENT
    Purpose Procedures Potential risks and benefits Individual rights

    SCIENTIFIC REVIEW
    Institutional review boards (IRBs) are required by federal law for trials that are: --Federally funded --Subject to FDA regulation

    DATA AND SAFETY MOBITORING BOARDS Ensure that risks are minimized Ensure data integrity Stop a trial if safety concerns arise or objectives have been met

    Sometimes patients: Dont know about clinical trials Dont have access to clinical trials May be afraid or suspicious of research Cant afford to participate May not want to go against health care providers wishes

    REASONS FOR FEW PEOPLE PARTICIPATING IN CLINICAL TRIALS

    Health care providers might: Lack awareness of appropriate clinical trials Be unwilling to lose control of a persons care Believe that standard therapy is best Be concerned that clinical trials add administrative burdens

    You might also like